Top

Published in:

01-04-2020 | Obesity | Review

Neuronal control of peripheral nutrient partitioning

Authors: Romane Manceau, Danie Majeur, Thierry Alquier

Published in: Diabetologia | Issue 4/2020

Abstract

The appropriate utilisation, storage and conversion of nutrients in peripheral tissues, referred to as nutrient partitioning, is a fundamental process to adapt to nutritional and metabolic challenges and is thus critical for the maintenance of a healthy energy balance. Alterations in this process during nutrient excess can have deleterious effects on glucose and lipid homeostasis and contribute to the development of obesity and type 2 diabetes. Nutrient partitioning is a complex integrated process under the control of hormonal and neural signals. Neural control relies on the capacity of the brain to sense circulating metabolic signals and mount adaptive neuroendocrine and autonomic responses. This review aims to discuss the hypothalamic neurocircuits and molecular mechanisms controlling nutrient partitioning and their potential contribution to metabolic maladaptation and disease.

Available only for authorised users

Ghosh S, Bouchard C (2017) Convergence between biological, behavioural and genetic determinants of obesity. Nat Rev Genet 18(12):731–748. https://doi.org/10.1038/nrg.2017.72 CrossRefPubMed

Locke AE, Kahali B, Berndt SI et al (2015) Genetic studies of body mass index yield new insights for obesity biology. Nature 518(7538):197–206. https://doi.org/10.1038/nature14177 CrossRefPubMedPubMedCentral

Justice AE, Karaderi T, Highland HM et al (2019) Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution. Nat Genet 51(3):452–469. https://doi.org/10.1038/s41588-018-0334-2 CrossRefPubMedPubMedCentral

Hall KD, Guo J (2017) Obesity energetics: body weight regulation and the effects of diet composition. Gastroenterology 152(7):1718–1727 e1713. https://doi.org/10.1053/j.gastro.2017.01.052 CrossRefPubMedPubMedCentral

Goodpaster BH, Sparks LM (2017) Metabolic flexibility in health and disease. Cell Metab 25(5):1027–1036. https://doi.org/10.1016/j.cmet.2017.04.015 CrossRefPubMedPubMedCentral

Myers MG Jr, Olson DP (2012) Central nervous system control of metabolism. Nature 491(7424):357–363. https://doi.org/10.1038/nature11705 CrossRefPubMed

Shimazu T (1981) Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia 20(1):343–356. https://doi.org/10.1007/BF00254502 CrossRefPubMed

Flier JS (2019) Starvation in the midst of plenty: reflections on the history and biology of insulin and leptin. Endocr Rev 40(1):1–16. https://doi.org/10.1210/er.2018-00179 CrossRefPubMed

Flier JS, Maratos-Flier E (2017) Leptin’s physiologic role: does the emperor of energy balance have no clothes? Cell Metab 26(1):24–26. https://doi.org/10.1016/j.cmet.2017.05.013 CrossRefPubMed

10.

Zhao S, Zhu Y, Schultz RD et al (2019) Partial leptin reduction as an insulin sensitization and weight loss strategy. Cell Metab 30(4):706–719 e706. https://doi.org/10.1016/j.cmet.2019.08.005 CrossRefPubMed

11.

Minokoshi Y, Kim Y-B, Peroni OD et al (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415(6869):339–343. https://doi.org/10.1038/415339a CrossRefPubMed

12.

Huynh FK, Levi J, Denroche HC et al (2010) Disruption of hepatic leptin signaling protects mice from age- and diet-related glucose intolerance. Diabetes 59(12):3032–3040. https://doi.org/10.2337/db10-0074 CrossRefPubMedPubMedCentral

13.

Pereira S, O’Dwyer SM, Webber TD et al (2019) Metabolic effects of leptin receptor knockdown or reconstitution in adipose tissues. Sci Rep 9(1):3307. https://doi.org/10.1038/s41598-019-39498-3 CrossRefPubMedPubMedCentral

14.

Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ (1997) Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389(6649):374–377. https://doi.org/10.1038/38717 CrossRefPubMed

15.

Minokoshi Y, Haque MS, Shimazu T (1999) Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes 48(2):287–291. https://doi.org/10.2337/diabetes.48.2.287 CrossRefPubMed

16.

Coppari R, Ichinose M, Lee CE et al (2005) The hypothalamic arcuate nucleus: a key site for mediating leptin’s effects on glucose homeostasis and locomotor activity. Cell Metab 1(1):63–72. https://doi.org/10.1016/j.cmet.2004.12.004 CrossRefPubMed

17.

Morton GJ, Gelling RW, Niswender KD, Morrison CD, Rhodes CJ, Schwartz MW (2005) Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab 2(6):411–420. https://doi.org/10.1016/j.cmet.2005.10.009 CrossRefPubMed

18.

Fujikawa T, Berglund ED, Patel VR et al (2013) Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin. Cell Metab 18(3):431–444. https://doi.org/10.1016/j.cmet.2013.08.004 CrossRefPubMedPubMedCentral

19.

Perry RJ, Zhang XM, Zhang D et al (2014) Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Med 20(7):759–763. https://doi.org/10.1038/nm.3579 CrossRefPubMedPubMedCentral

20.

Neumann UH, Denroche HC, Mojibian M, Covey SD, Kieffer TJ (2016) Insulin knockout mice have extended survival but volatile blood glucose levels on leptin therapy. Endocrinology 157(3):1007–1012. https://doi.org/10.1210/en.2015-1890 CrossRefPubMed

21.

Zeng W, Pirzgalska RM, Pereira MM et al (2015) Sympathetic neuro-adipose connections mediate leptin-driven lipolysis. Cell 163(1):84–94. https://doi.org/10.1016/j.cell.2015.08.055 CrossRefPubMed

22.

Hackl MT, Fürnsinn C, Schuh CM et al (2019) Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis. Nat Commun 10(1):2717. https://doi.org/10.1038/s41467-019-10684-1 CrossRefPubMedPubMedCentral

23.

Mora C, Pintado C, Rubio B et al (2018) Central leptin regulates heart lipid content by selectively increasing PPAR beta/delta expression. J Endocrinol 236(1):43–56. https://doi.org/10.1530/joe-17-0554 CrossRefPubMed

24.

Caron A, Richard D (2017) Neuronal systems and circuits involved in the control of food intake and adaptive thermogenesis. Ann N Y Acad Sci 1391(1):35–53. https://doi.org/10.1111/nyas.13263 CrossRefPubMed

25.

Krashes MJ, Lowell BB, Garfield AS (2016) Melanocortin-4 receptor-regulated energy homeostasis. Nat Neurosci 19(2):206–219. https://doi.org/10.1038/nn.4202 CrossRefPubMedPubMedCentral

26.

Kim KS, Seeley RJ, Sandoval DA (2018) Signalling from the periphery to the brain that regulates energy homeostasis. Nat Rev Neurosci 19(4):185–196. https://doi.org/10.1038/nrn.2018.8 CrossRefPubMed

27.

Joly-Amado A, Denis RG, Castel J et al (2012) Hypothalamic AgRP-neurons control peripheral substrate utilization and nutrient partitioning. EMBO J 31(22):4276–4288. https://doi.org/10.1038/emboj.2012.250 CrossRefPubMedPubMedCentral

28.

Cavalcanti-de-Albuquerque JP, Bober J, Zimmer MR, Dietrich MO (2019) Regulation of substrate utilization and adiposity by Agrp neurons. Nat Commun 10(1):311. https://doi.org/10.1038/s41467-018-08239-x CrossRefPubMedPubMedCentral

29.

Nogueiras R, Wiedmer P, Perez-Tilve D et al (2007) The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 117(11):3475–3488. https://doi.org/10.1172/JCI31743 CrossRefPubMedPubMedCentral

30.

Perez-Tilve D, Hofmann SM, Basford J et al (2010) Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci 13(7):877–882. https://doi.org/10.1038/nn.2569 CrossRefPubMedPubMedCentral

31.

Kooijman S, Boon MR, Parlevliet ET et al (2014) Inhibition of the central melanocortin system decreases brown adipose tissue activity. J Lipid Res 55(10):2022–2032. https://doi.org/10.1194/jlr.M045989 CrossRefPubMedPubMedCentral

32.

Brito MN, Brito NA, Baro DJ, Song CK, Bartness TJ (2007) Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology 148(11):5339–5347. https://doi.org/10.1210/en.2007-0621 CrossRefPubMed

33.

da Silva AA, do Carmo JM, Freeman JN, Tallam LS, Hall JE (2009) A functional melanocortin system may be required for chronic CNS-mediated antidiabetic and cardiovascular actions of leptin. Diabetes 58(8):1749–1756. https://doi.org/10.2337/db08-1221 CrossRefPubMedPubMedCentral

34.

Goncalves GH, Li W, Garcia AV, Figueiredo MS, Bjorbaek C (2014) Hypothalamic agouti-related peptide neurons and the central melanocortin system are crucial mediators of leptin's antidiabetic actions. Cell Rep 7(4):1093–1103. https://doi.org/10.1016/j.celrep.2014.04.010 CrossRefPubMedPubMedCentral

35.

Xu J, Bartolome CL, Low CS et al (2018) Genetic identification of leptin neural circuits in energy and glucose homeostases. Nature 556(7702):505–509. https://doi.org/10.1038/s41586-018-0049-7 CrossRefPubMedPubMedCentral

36.

Singha AK, Yamaguchi J, Gonzalez NS, Ahmed N, Toney GM, Fujikawa T (2019) Glucose-lowering by leptin in the absence of insulin does not fully rely on the central melanocortin system in male mice. Endocrinology 160(3):651–663. https://doi.org/10.1210/en.2018-00907 CrossRefPubMedPubMedCentral

37.

Williams KW, Liu T, Kong X et al (2014) Xbp1s in Pomc neurons connects ER stress with energy balance and glucose homeostasis. Cell Metab 20(3):471–482. https://doi.org/10.1016/j.cmet.2014.06.002 CrossRefPubMedPubMedCentral

38.

Dodd GT, Decherf S, Loh K et al (2015) Leptin and insulin act on POMC neurons to promote the browning of white fat. Cell 160(1–2):88–104. https://doi.org/10.1016/j.cell.2014.12.022 CrossRefPubMedPubMedCentral

39.

Ruan HB, Dietrich MO, Liu ZW et al (2014) O-GlcNAc transferase enables AgRP neurons to suppress browning of white fat. Cell 159(2):306–317. https://doi.org/10.1016/j.cell.2014.09.010 CrossRefPubMedPubMedCentral

40.

Schneider MK, Xue B, Shi H (2018) Activation of the sympathetic nervous system suppresses mouse white adipose tissue hyperplasia through the β1 adrenergic receptor. Physiol Rep 6(7):e13645. https://doi.org/10.14814/phy2.13645 CrossRefPubMedPubMedCentral

41.

Holland J, Sorrell J, Yates E et al (2019) A brain-melanocortin-vagus axis mediates adipose tissue expansion independently of energy intake. Cell Rep 27(8):2399–2410.e2396. https://doi.org/10.1016/j.celrep.2019.04.089 CrossRefPubMedPubMedCentral

42.

Verberne AJM, Sabetghadam A, Korim WS (2014) Neural pathways that control the glucose counterregulatory response. Front Neurosci 8:38–38. https://doi.org/10.3389/fnins.2014.00038 CrossRefPubMedPubMedCentral

43.

Tong Q, Ye C, McCrimmon RJ et al (2007) Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab 5(5):383–393. https://doi.org/10.1016/j.cmet.2007.04.001 CrossRefPubMedPubMedCentral

44.

Meek TH, Nelson JT, Matsen ME et al (2016) Functional identification of a neurocircuit regulating blood glucose. Proc Natl Acad Sci U S A 113(14):E2073–E2082. https://doi.org/10.1073/pnas.1521160113 CrossRefPubMedPubMedCentral

45.

Chan O, Cheng H, Herzog R et al (2008) Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Diabetes 57(5):1363–1370. https://doi.org/10.2337/db07-1559 CrossRefPubMedPubMedCentral

46.

Hedrington MS, Farmerie S, Ertl AC, Wang Z, Tate DB, Davis SN (2010) Effects of antecedent GABA_A activation with alprazolam on counterregulatory responses to hypoglycemia in healthy humans. Diabetes 59(4):1074–1081. https://doi.org/10.2337/db09-1520 CrossRefPubMedPubMedCentral

47.

Hedrington MS, Mikeladze M, Tate DB, Younk LM, Davis I, Davis SN (2016) Effects of γ-aminobutyric acid a receptor activation on counterregulatory responses to subsequent exercise in individuals with type 1 diabetes. Diabetes 65(9):2754–2759. https://doi.org/10.2337/db16-0207 CrossRefPubMedPubMedCentral

48.

Wolfgang MJ, Cha SH, Sidhaye A et al (2007) Regulation of hypothalamic malonyl-CoA by central glucose and leptin. Proc Natl Acad Sci U S A 104(49):19285–19290. https://doi.org/10.1073/pnas.0709778104 CrossRefPubMedPubMedCentral

49.

Taib B, Bouyakdan K, Hryhorczuk C, Rodaros D, Fulton S, Alquier T (2013) Glucose regulates hypothalamic long-chain fatty acid metabolism via AMP-activated kinase (AMPK) in neurons and astrocytes. J Biol Chem 288(52):37216–37229. https://doi.org/10.1074/jbc.M113.506238 CrossRefPubMedPubMedCentral

50.

Cha SH, Hu Z, Chohnan S, Lane MD (2005) Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. Proc Natl Acad Sci U S A 102(41):14557–14562. https://doi.org/10.1073/pnas.0507300102 CrossRefPubMedPubMedCentral

51.

Hu Z, Dai Y, Prentki M, Chohnan S, Lane MD (2005) A role for hypothalamic malonyl-CoA in the control of food intake. J Biol Chem 280(48):39681–39683. https://doi.org/10.1074/jbc.C500398200 CrossRefPubMed

52.

He W, Lam TKT, Obici S, Rossetti L (2006) Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat Neurosci 9(2):227–233. https://doi.org/10.1038/nn1626 CrossRefPubMed

53.

Obici S, Feng Z, Arduini A, Conti R, Rossetti L (2003) Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9(6):756–761. https://doi.org/10.1038/nm873 CrossRefPubMed

54.

Lam TK, Pocai A, Gutierrez-Juarez R et al (2005) Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 11(3):320–327. https://doi.org/10.1038/nm1201 CrossRefPubMed

55.

Muoio DM, Noland RC, Kovalik JP et al (2012) Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab 15(5):764–777. https://doi.org/10.1016/j.cmet.2012.04.005 CrossRefPubMedPubMedCentral

56.

Seiler SE, Koves TR, Gooding JR et al (2015) Carnitine acetyltransferase mitigates metabolic inertia and muscle fatigue during exercise. Cell Metab 22(1):65–76. https://doi.org/10.1016/j.cmet.2015.06.003 CrossRefPubMedPubMedCentral

57.

Reichenbach A, Stark R, Mequinion M et al (2018) AgRP neurons require carnitine acetyltransferase to regulate metabolic flexibility and peripheral nutrient partitioning. Cell Rep 22(7):1745–1759. https://doi.org/10.1016/j.celrep.2018.01.067 CrossRefPubMed

58.

Reichenbach A, Stark R, Mequinion M, et al (2018) Carnitine acetyltransferase (Crat) in hunger-sensing AgRP neurons permits adaptation to calorie restriction. FASEB J: fj201800634R. https://doi.org/10.1096/fj.201800634R

59.

Stark R, Reichenbach A, Andrews ZB (2015) Hypothalamic carnitine metabolism integrates nutrient and hormonal feedback to regulate energy homeostasis. Mol Cell Endocrinol 418(Pt 1):9–16. https://doi.org/10.1016/j.mce.2015.08.002 CrossRefPubMed

60.

Coupe B, Ishii Y, Dietrich MO, Komatsu M, Horvath TL, Bouret SG (2012) Loss of autophagy in pro-opiomelanocortin neurons perturbs axon growth and causes metabolic dysregulation. Cell Metab 15(2):247–255. https://doi.org/10.1016/j.cmet.2011.12.016 CrossRefPubMedPubMedCentral

61.

Kaushik S, Arias E, Kwon H et al (2012) Loss of autophagy in hypothalamic POMC neurons impairs lipolysis. EMBO Rep 13(3):258–265. https://doi.org/10.1038/embor.2011.260 CrossRefPubMedPubMedCentral

62.

Quan W, Kim HK, Moon EY et al (2012) Role of hypothalamic proopiomelanocortin neuron autophagy in the control of appetite and leptin response. Endocrinology 153(4):1817–1826. https://doi.org/10.1210/en.2011-1882 CrossRefPubMed

63.

Martinez-Lopez N, Garcia-Macia M, Sahu S et al (2016) Autophagy in the CNS and periphery coordinate lipophagy and lipolysis in the brown adipose tissue and liver. Cell Metab 23(1):113–127. https://doi.org/10.1016/j.cmet.2015.10.008 CrossRefPubMed

64.

Xiao Y, Deng Y, Yuan F et al (2017) An ATF4-ATG5 signaling in hypothalamic POMC neurons regulates obesity. Autophagy 13(6):1088–1089. https://doi.org/10.1080/15548627.2017.1307488 CrossRefPubMedPubMedCentral

65.

Kaushik S, Rodriguez-Navarro JA, Arias E et al (2011) Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance. Cell Metab 14(2):173–183. https://doi.org/10.1016/j.cmet.2011.06.008 CrossRefPubMedPubMedCentral

66.

Zhang Y, Sowers JR, Ren J (2018) Targeting autophagy in obesity: from pathophysiology to management. Nat Rev Endocrinol 14(6):356–376. https://doi.org/10.1038/s41574-018-0009-1 CrossRefPubMed

67.

Minokoshi Y, Alquier T, Furukawa N et al (2004) AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428(6982):569–574. https://doi.org/10.1038/nature02440 CrossRefPubMed

68.

Cota D, Proulx K, Smith KA et al (2006) Hypothalamic mTOR signaling regulates food intake. Science 312(5775):927–930. https://doi.org/10.1126/science.1124147 CrossRefPubMed

69.

Gao S, Kinzig KP, Aja S et al (2007) Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. Proc Natl Acad Sci U S A 104(44):17358–17363. https://doi.org/10.1073/pnas.0708385104 CrossRefPubMedPubMedCentral

70.

Andrews ZB, Liu ZW, Walllingford N et al (2008) UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals. Nature 454(7206):846–851. https://doi.org/10.1038/nature07181 CrossRefPubMedPubMedCentral

71.

Lopez M, Lage R, Saha AK et al (2008) Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 7(5):389–399. https://doi.org/10.1016/j.cmet.2008.03.006 CrossRefPubMed

72.

Sandoval D, Barrera JG, Stefater MA et al (2012) The anorectic effect of GLP-1 in rats is nutrient dependent. PLoS One 7(12):e51870. https://doi.org/10.1371/journal.pone.0051870 CrossRefPubMedPubMedCentral

73.

Burmeister MA, Ayala J, Drucker DJ, Ayala JE (2013) Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose. Am J Physiol Endocrinol Metab 304(7):E677–E685. https://doi.org/10.1152/ajpendo.00446.2012 CrossRefPubMed

74.

Lockie SH, Stark R, Mequinion M et al (2018) Glucose availability predicts the feeding response to ghrelin in male mice, an effect dependent on AMPK in AgRP neurons. Endocrinology 159(11):3605–3614. https://doi.org/10.1210/en.2018-00536 CrossRefPubMedPubMedCentral

75.

Chen KY, Muniyappa R, Abel BS et al (2015) RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals. J Clin Endocrinol Metab 100(4):1639–1645. https://doi.org/10.1210/jc.2014-4024 CrossRefPubMedPubMedCentral

76.

Kuhnen P, Krude H, Biebermann H (2019) Melanocortin-4 receptor signalling: importance for weight regulation and obesity treatment. Trends Mol Med 25(2):136–148. https://doi.org/10.1016/j.molmed.2018.12.002 CrossRefPubMed

77.

Brown RJ, Valencia A, Startzell M et al (2018) Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy. J Clin Invest 128(8):3504–3516. https://doi.org/10.1172/JCI95476 CrossRefPubMedPubMedCentral

78.

Guarino D, Nannipieri M, Iervasi G, Taddei S, Bruno RM (2017) The role of the autonomic nervous system in the pathophysiology of obesity. Front Physiol 8:665. https://doi.org/10.3389/fphys.2017.00665 CrossRefPubMedPubMedCentral

79.

Morton GJ, Matsen ME, Bracy DP et al (2013) FGF19 action in the brain induces insulin-independent glucose lowering. J Clin Invest 123(11):4799–4808. https://doi.org/10.1172/jci70710 CrossRefPubMedPubMedCentral

80.

Marcelin G, Jo YH, Li X et al (2014) Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism. Mol Metab 3(1):19–28. https://doi.org/10.1016/j.molmet.2013.10.002 CrossRefPubMed

81.

Scarlett JM, Rojas JM, Matsen ME et al (2016) Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents. Nat Med 22(7):800–806. https://doi.org/10.1038/nm.4101 CrossRefPubMedPubMedCentral

82.

Brandt C, Nolte H, Henschke S et al (2018) Food perception primes hepatic ER homeostasis via melanocortin-dependent control of mTOR activation. Cell 175(5):1321–1335.e1320. https://doi.org/10.1016/j.cell.2018.10.015 CrossRefPubMedPubMedCentral

Title: Neuronal control of peripheral nutrient partitioning
Authors: Romane Manceau
Danie Majeur
Thierry Alquier
Publication date: 01-04-2020
Publisher: Springer Berlin Heidelberg
Keywords: Obesity
Obesity
Published in: Diabetologia / Issue 4/2020
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-020-05104-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2020

Correction to: Altered mitochondrial bioenergetics and ultrastructure in the skeletal muscle of young adults with type 1 diabetes

Referees 2019

Pregnant women with gestational diabetes and with well controlled glucose levels have decreased concentrations of individual fatty acids in maternal and cord serum

Vascular improvements in individuals with type 2 diabetes following a 1 year randomised controlled exercise intervention, irrespective of changes in cardiorespiratory fitness

An adipocyte-specific defect in oxidative phosphorylation increases systemic energy expenditure and protects against diet-induced obesity in mouse models

Red meat, poultry and fish consumption and risk of diabetes: a 9 year prospective cohort study of the China Kadoorie Biobank

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage